<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-id journal-id-type="publisher-id">CI</journal-id><journal-id journal-id-type="publisher-id">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>e-Med</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23545125</article-id><article-id pub-id-type="pmc">3613791</article-id><article-id pub-id-type="doi">10.1102/1470-7330.2013.0013</article-id><article-id pub-id-type="publisher-id">ci130013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Imaging of thyroid carcinoma with CT and MRI: approaches to common scenarios</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Hoang</surname><given-names>Jenny K.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Branstetter</surname><given-names>Barton F.</given-names><suffix>IV</suffix></name><xref ref-type="aff" rid="AFF1"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gafton</surname><given-names>Andreia R.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Wai K.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Glastonbury</surname><given-names>Christine M.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>e</sup></xref></contrib></contrib-group><aff id="AFF1"><sup>a</sup>Department of Radiology and Radiation Oncology, Duke University Medical Center, Durham, NC, USA; <sup>b</sup>Departments of Radiology, Otolaryngology, and Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA; <sup>c</sup>Department of Radiology, Yale School of Medicine, New Haven, CT, USA; <sup>d</sup>Department of Radiology, St Vincent&#x02019;s Hospital Melbourne and University of Melbourne, Melbourne, Australia; <sup>e</sup>Departments of Radiology and Biomedical Imaging, Otolaryngology-Head and Neck Surgery, and Radiation Oncology, University of California, San Francisco, CA, USA</aff><author-notes><corresp>Corresponding address: Jenny K. Hoang, Department of Radiology, Duke University Medical Center, Box 3808, Erwin Road, Durham NC, 27710, USA. Email: <monospace><email>jennykh@gmail.com</email></monospace></corresp></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>26</day><month>3</month><year>2013</year></pub-date><volume>13</volume><issue>1</issue><fpage>128</fpage><lpage>139</lpage><history><date date-type="accepted"><day>18</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 International Cancer Imaging Society</copyright-statement><copyright-year>2013</copyright-year></permissions><abstract><title>Abstract</title><p>Computed tomography (CT) and magnetic resonance imaging (MRI) can play an important role in preoperative and post-treatment assessment of thyroid malignancy. The radiologist should be aware of the pathological behavior of thyroid carcinoma, and the characteristic imaging appearance of the primary tumor and metastases. This review describes the approach to imaging thyroid cancer on CT and MRI for four common scenarios: detection of the incidental thyroid nodule, evaluation of thyroid metastases, presurgical imaging for invasive disease, and evaluation for recurrence in the post-treatment neck.</p></abstract><kwd-group><title>Keywords</title><kwd>Thyroid cancer</kwd><kwd>computed tomography</kwd><kwd>magnetic resonance imaging</kwd><kwd>incidental thyroid nodule</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Although sonography is the primary imaging test for a palpable thyroid nodule or known thyroid malignancy<sup>[</sup><xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>]</sup>, thyroid abnormalities are frequently first discovered on other cross-sectional modalities of computed tomography (CT) and magnetic resonance imaging (MRI). A thyroid lesion may be seen as an incidental finding, or CT and MRI may be first used for evaluation of an unknown neck mass.</p><p>This review describes four common scenarios in which CT and MR imaging of thyroid carcinoma may arise: detection of the incidental thyroid nodule (ITN), evaluation of thyroid nodal metastases, presurgical imaging for invasive disease, and evaluation for recurrence in the post-treatment neck.</p></sec><sec><title>Histological types and risk factors</title><p>The incidence of thyroid cancer is estimated at 37,000 per year in the United States and has more than doubled over the last 30 years<sup>[</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>]</sup>. This has been largely attributed to an increased work-up of incidentally detected thyroid nodules on imaging. Most primary thyroid carcinomas are papillary (88%), follicular (8%), medullary (1%) or anaplastic (1%)<sup>[</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>]</sup>. These four histopathologies are the focus of this article. Other primary cancers of the thyroid such as squamous cell carcinoma (SCCa), sarcoma and lymphoma are extremely rare (combined less than 1%).</p><p>Papillary and follicular carcinomas (including Hurthle cell variant of follicular) are known as differentiated thyroid carcinomas (DTC). Both have an excellent prognosis with 10-year survival rates of greater than 95% and 85%, respectively<sup>[</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>]</sup>. In particular, small papillary cancers have indolent behavior. Epidemiological studies show the absence of a survival improvement despite increased diagnosis of small thyroid cancers, and a Japanese study showed no deaths over 10 years in non-aggressive small thyroid carcinomas that did not receive treatment<sup>[</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>]</sup>.</p><p>Medullary thyroid carcinoma (MTC) arises from neuroendocrine C cells in the thyroid gland that produce calcitonin. The survival rate (75% at 10 years) is still favorable<sup>[</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref><sup>]</sup>. Anaplastic carcinoma is an aggressive undifferentiated tumor typically occurring in the elderly with a 5-year survival rate of 7%<sup>[</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>]</sup>.</p><p>Risk factors are different for each histological type. Papillary carcinoma is associated with ionizing radiation exposure, particularly childhood head and neck irradiation, or total body irradiation for bone marrow transplantation<sup>[</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>]</sup>. Family history of thyroid carcinoma with or without a thyroid carcinoma syndrome is also an important risk factor for DTC and for MTC. A quarter of cases of MTC are associated with familial medullary thyroid carcinoma (FMTC), which is due to inherited mutations in the protooncogene RET<sup>[</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>]</sup>. The combination of FMTC and tumors of other endocrine glands is called multiple endocrine neoplasia (MEN). Other familial syndromes associated with MTC include Cowden syndrome, familial polyposis, Carney complex and Werner syndrome. In developing countries, follicular carcinoma and anaplastic carcinoma have been associated with a diet low in iodine.</p></sec><sec><title>Imaging protocol</title><p>Communication with the clinician is important before performing a contrast CT scan in a patient with known thyroid malignancy. In many cases, a noncontrast study is preferred because the free iodide load of contrast medium injections interferes with iodide uptake in the thyroid for at least 6&#x02013;8 weeks<sup>[</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>]</sup>. For patients with DTC, this compromises the use of diagnostic thyroid scintigraphy and radioiodine ablation for 2&#x02013;6 months depending on the institution<sup>[</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref><sup>]</sup>. MRI contrast (gadolinium) does not interfere with iodine uptake.</p><p>CT imaging at our institutions involves multidetector acquisition from the skull base to the tracheal bifurcation with or without contrast. Multiplanar 2-mm axial, coronal and sagittal images are provided for interpretation. Our MRI protocol has a similar coverage from the skull base to the tracheal bifurcation and includes the following sequences: axial and coronal T1-weighted and fat-saturated T2-weighted images, followed by post-contrast axial and coronal T1-weighted images.</p></sec><sec><title>Imaging with CT and MRI</title><sec><title>ITN on CT and MRI</title><p>With increased use of CT and MRI, ITNs or so-called thyroid incidentalomas are becoming a growing problem. ITNs are common and present in up to 1 in 6 CT studies of the neck<sup>[</sup><xref ref-type="bibr" rid="B11 B12 B13"><sup>11&#x02013;13</sup></xref><sup>]</sup>. The decision to report the nodule is difficult because in the absence of frank local invasion or fluorodeoxyglucose (FDG)-positron emission tomography (PET) focal uptake, there are no findings on CT and routine MRI to reliably identify the malignant lesions<sup>[</sup><xref ref-type="bibr" rid="B14 B15 B16"><sup>14&#x02013;16</sup></xref><sup>]</sup>. Studies have shown value in adding diffusion-weighted imaging to neck MRI because benign nodules have a higher apparent diffusion coefficient value, but the preferred modality for work-up is still ultrasonography<sup>[</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>]</sup>.</p><p>Arguments against work-up of small ITNs with ultrasonography are that the malignancy rate in the incidental nodule is low, ranging from 0 to 9%<sup>[</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19 B20 B21 B22"><sup>19&#x02013;22</sup></xref><sup>]</sup>, and, as discussed, the prognosis of malignancy is excellent with many patients dying with, rather than of, thyroid carcinoma<sup>[</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>]</sup>. Despite these favorable factors, radiologists still worry about missing malignancy. Many struggle with the balance of being cost-effective about recommending further imaging and the fear of missing a potential tumor<sup>[</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>]</sup>.</p><p>Without guidelines for reporting ITNs on CT and MRI, previous authors have suggested extrapolating from sonographic criteria for fine-needle aspiration biopsy and using a size cut-off of 10&#x02009;mm or 15&#x02009;mm to triage nodules detected on CT or MRI for work-up<sup>[</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>]</sup>. The most common method for selecting a CT-detected ITN for ultrasonography is to use a 10-mm size cut-off<sup>[</sup><xref ref-type="bibr" rid="B25"><sup>25</sup></xref><sup>]</sup>. The disadvantage of this method is that a large number of benign nodules would qualify for work-up: up to 78% of incidentally detected nodules on CT would require sonography<sup>[</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref><sup>]</sup>. Hoang et al.<sup>[</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>]</sup> recently proposed a strategy for reporting ITNs seen on cross-sectional imaging based on prioritizing subsets of patients who are more likely to have malignant nodules. Their 3-tiered system selects nodules for work-up based on nodule size but also imaging features of advanced malignant disease and young patient age. A modified version of this reporting system (<xref ref-type="table" rid="T1">Table 1</xref>) was recently applied to a single institution&#x02019;s cohort of 133 CT-detected incidental nodules and the National Cancer Institute&#x02019;s SEER database of thyroid carcinoma. Compared with using a 10-mm size cut-off alone, the 3-tiered risk stratification method, with a 15-mm nodule size cut-off, identified almost half the number of ITNs for work-up, but captured the same proportion of cancers; there was no difference in the high-mortality cancers missed<sup>[</sup><xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>]</sup>.
<table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The 3-tiered system of risk categories for thyroid nodules detected by CT, MRI or PET</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Category</th><th rowspan="1" colspan="1">Characteristic of incidental nodules</th><th rowspan="1" colspan="1">Suggested work-up recommendations</th></tr></thead><tbody align="left"><tr><td rowspan="4" colspan="1">Risk category 1: highly suspicious for malignancy</td><td rowspan="1" colspan="1">PET avid thyroid nodule</td><td rowspan="4" colspan="1">Recommend fine-needle aspiration</td></tr><tr><td rowspan="1" colspan="1">Associated lymphadenopathy</td></tr><tr><td rowspan="1" colspan="1">Extrathyroid spread with or without signs of vocal cord palsy on side of nodule</td></tr><tr><td rowspan="1" colspan="1">Lung metastases</td></tr><tr><td rowspan="3" colspan="1">Risk category 2: indeterminate with risk factors</td><td rowspan="1" colspan="1">High-risk history<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="2" colspan="1">Recommend ultrasonography for further characterization</td></tr><tr><td rowspan="1" colspan="1">Demographics: female &#x0003c;20 years or male &#x0003c;35 years</td></tr><tr><td rowspan="1" colspan="1">Demographics: female 20&#x02013;35 years</td><td rowspan="1" colspan="1">Comment that ultrasonography for characterization can be considered given the young age</td></tr><tr><td rowspan="2" colspan="1">Risk category 3: indeterminate without risk factors</td><td rowspan="1" colspan="1">&#x0003e;1.5&#x02009;cm or substantial interval growth</td><td rowspan="1" colspan="1">Describe in the impression</td></tr><tr><td rowspan="1" colspan="1">&#x02264;1.5&#x02009;cm</td><td rowspan="1" colspan="1">Describe in body of report only</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p><sup>a</sup>High-risk history: history of thyroid cancer in one or more first-degree relatives; history of external beam radiation as a child; exposure to ionizing radiation in childhood or adolescence; previous hemithyroidectomy with discovery of thyroid cancer, MEN2/FMTC-associated RET protooncogene mutation, calcitonin &#x0003e;100&#x02009;pg/ml. MEN, multiple endocrine neoplasia; FMTC, familial medullary thyroid cancer.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Evaluating for nodal metastases</title><p>Papillary carcinoma and MTC are the most common thyroid cancers to metastasize to lymph nodes, whereas nodal metastases are uncommon in follicular carcinoma. Nodal masses may be the first presentation for papillary carcinoma and MTC, and CT or MRI may be performed to search for an unknown primary. In this setting, any thyroid nodule should be regarded as suspicious and warrant further evaluation with ultrasonography. The radiologist should also be aware that some thyroid primaries may not be seen on CT and MRI as they may be small, diffuse or multifocal (<xref ref-type="fig" rid="F1">Figs. 1</xref> and <xref ref-type="fig" rid="F2">2</xref>)<sup>[</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>]</sup>.
<fig id="F1" position="float"><label>Figure 1</label><caption><p>A 58-year-old man with papillary thyroid carcinoma presenting with large cystic nodal metastases and occult primary on imaging. (a) Axial enhanced CT image shows bilateral neck cystic masses, larger on the left (arrows). The thyroid had normal appearance on CT without focal lesions. The gland was also normal on sonography (not shown). (b) Coronal reformatted enhanced CT image shows multiple complex solid cystic masses in lateral nodal groups, levels II, III and IV on the left and level IV on the right (arrows). There are similar smaller cystic masses inferior to both lobes of the thyroid gland in keeping with level VI nodes (curved arrows). Fine-needle aspiration of one of the nodes revealed psammoma bodies and stained positive for thyroglobulin, which was diagnostic of papillary carcinoma. The surgical specimen from total thyroidectomy found multifocal papillary carcinomas of various sizes from 0.1&#x02009;cm to 1.4&#x02009;cm in the isthmus and both lobes.</p></caption><graphic xlink:href="ci13001301"/></fig>
<fig id="F2" position="float"><label>Figure 2</label><caption><p>A 61-year-old man with papillary thyroid carcinoma in both thyroid lobes and bilateral nodal metastases of varying morphological appearance and size. Coronal enhanced CT image shows the primary tumor as a large heterogeneous mass in the inferior left thyroid lobe with areas of coarse and eggshell calcifications (arrowheads). There is a large heterogeneous left level III nodal metastasis (asterisk). The inferior right lobe of the thyroid has a subtle low attenuation region (black arrow), which was also malignant on the total thyroidectomy specimen. There are small cystic nodal metastases in the right level VI and level II nodal groups (curved arrows) of different morphology from the large left neck mass.</p></caption><graphic xlink:href="ci13001302"/></fig></p><p>In a patient presenting with adenopathy, the findings from a nodal mass that suggest a primary thyroid origin include cystic components (<xref ref-type="fig" rid="F1 F2 F3">Figs. 1&#x02013;3</xref>), calcification (<xref ref-type="fig" rid="F2">Figs. 2</xref> and <xref ref-type="fig" rid="F4">4</xref>), intense enhancement, or proteinaceous or hemorrhagic content appearing as hyperdensity on CT and T1 hyperintensity on MRI<sup>[</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref><sup>]</sup>. It is important that cystic neck masses in young adults are not dismissed as congenital cysts, but considered SCCa or thyroid carcinoma until proven otherwise (<xref ref-type="fig" rid="F3">Fig. 3</xref>).
<fig id="F3" position="float"><label>Figure 3</label><caption><p>A 19-year-old woman with papillary thyroid carcinoma presenting with cystic nodal metastases. Axial enhanced CT image shows a radiographically simple cyst (arrowheads) that actually represents a right level IV nodal metastasis. The right internal jugular vein is compressed anterior to the cyst indicating this lesion lies in the carotid space. There is a 1&#x02009;cm solid primary tumor in the right lobe of the thyroid with fine calcifications (arrow). The differential for a cystic neck mass in a young patient and particularly in a female is a cystic nodal metastasis from thyroid carcinoma, SCCa and a congenital cyst such as a branchial cleft cyst.</p></caption><graphic xlink:href="ci13001303"/></fig>
<fig id="F4" position="float"><label>Figure 4</label><caption><p>A 57-year-old man with MTC and coarsely calcified nodal metastases. Coronal reformatted unenhanced CT image shows a large coarsely calcified left level VI nodal mass. This is immediately inferior to the left lobe of the thyroid and was mistaken for a benign calcified hyperplastic thyroid nodule on initial ultrasonography before the CT. Several truly benign thyroid nodules were also found on ultrasonography leading to an incorrect diagnosis of multinodular goiter. CT showed other left level IIa and III nodal masses with coarse calcification, also representing MTC metastases (arrowheads).</p></caption><graphic xlink:href="ci13001304"/></fig></p><p>In patients with diagnosed thyroid malignancy, nodal staging is optimal if the radiologist is cognizant of the common sites of nodal metastases. Previous studies are useful resources for the location of the nodal groups<sup>[</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>]</sup>. Thyroid nodal metastases commonly occur in the central compartment (level VI) and the lateral nodal groups (levels II&#x02013;IV) (<xref ref-type="fig" rid="F1 F2 F3 F4 F5">Figs. 1&#x02013;5</xref>)<sup>[</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>]</sup>. The highest lymph node in the central compartment is the Delphian node or prelaryngeal lymph node (<xref ref-type="fig" rid="F5">Fig. 5</xref>) and involvement of this group in papillary thyroid cancer is predictive of advanced nodal disease in that patients are nine times more likely to have lateral nodal involvement<sup>[</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref><sup>]</sup>. Other nodal sites that should not be neglected are the lower paratracheal nodes in the superior mediastinum (level VII), and the retropharyngeal (<xref ref-type="fig" rid="F6">Fig. 6</xref>) and retroesophageal groups<sup>[</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>]</sup>. The American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) TNM staging system classifies nodal stage by site: N1a is level VI nodal disease (including pretracheal, paratracheal, and Delphian nodes), and N1b is involvement of unilateral or bilateral lateral cervical nodes, or superior mediastinal nodes<sup>[</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>]</sup>. The presence of superior mediastinal nodes may preclude surgery for curative intent so CT or MRI may be indicated if there are predictors of mediastinal disease such as lateral nodes or primary tumor greater than 1.5 cm<sup>[</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref><sup>]</sup>.
<fig id="F5" position="float"><label>Figure 5</label><caption><p>A 24-year-old woman with metastatic papillary carcinoma including a Delphian nodal metastasis. She presented with a right neck mass. Axial enhanced CT image shows a large mass in the right lobe of the thyroid. There are heterogeneously enhancing right level IV nodal masses (arrows) and an enlarged Delphian node (arrowhead).</p></caption><graphic xlink:href="ci13001305"/></fig>
<fig id="F6" position="float"><label>Figure 6</label><caption><p>A 52-year-old woman with papillary carcinoma and a retropharyngeal metastasis. She had a history of fibromyalgia and presented with 1 year of right-sided neck pain. On clinical examination, she was found to have right neck adenopathy and an enlarged right thyroid lobe, subsequently proven to contain papillary thyroid carcinoma. A contrast-enhanced CT scan was performed before thyroid carcinoma was suspected. (a) Axial enhanced CT image shows subtle asymmetry of the prevertebral muscles (arrows). (b) The same axial enhanced CT image with narrowed window width shows a metastatic right retropharyngeal node (arrow) to be much more conspicuous. This case highlights the subtlety of retropharyngeal nodes on CT, which may be even more problematic when contrast is not given.</p></caption><graphic xlink:href="ci13001306"/></fig></p><p>It is important to remember that assessment of abnormal nodal morphology is better than using size criteria for metastatic disease because up to 61% of nodal metastases may be less than 10&#x02009;mm in diameter<sup>[</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref><sup>]</sup>. Other special characteristics about thyroid nodal metastases are that discontinuous nodal metastases (skip metastases) occur in up to 21% of cases of MTC<sup>[</sup><xref ref-type="bibr" rid="B34"><sup>34</sup></xref><sup>]</sup>. Whereas nodal metastases are much less common with follicular thyroid carcinoma, local invasion and distant metastases to the bone and lung are more common (<xref ref-type="fig" rid="F7">Fig. 7</xref>).
<fig id="F7" position="float"><label>Figure 7</label><caption><p>A 51-year-old woman with follicular carcinoma with venous invasion. She presented with an enlarging neck mass. (a) Axial enhanced CT image demonstrates a heterogeneously enlarged thyroid gland (arrows), displacing the trachea to the right. This was biopsied and determined to be follicular carcinoma. There was no evidence of neck adenopathy, and what resembles a node in the left neck (arrowheads) represents intravenous extension of tumor in the left internal jugular vein (IJV). (b) Coronal reformatted enhanced CT image better delineates extension of tumor in the left IJV (arrowheads).</p></caption><graphic xlink:href="ci13001307"/></fig></p></sec><sec><title>Assessing invasion for preoperative planning</title><p>With the exception of most cases of anaplastic carcinoma, the treatment of thyroid carcinoma involves total or near total thyroidectomy, central nodal resection, and possible radioiodine ablation<sup>[</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>]</sup>. The management of small tumors less than 10&#x02009;mm may be limited to lobectomy, but if the small tumors are multifocal, treatment still involves total thyroidectomy and radioiodine ablation. CT and MRI cannot diagnose multifocal tumor and cannot reliably determine the histology of thyroid cancer. Preoperative work-up with imaging starts with ultrasonography to detect multifocal disease and lymphadenopathy. CT and MRI are performed if local invasion is suspected.</p><p>The implication of locally invasive carcinoma may be more extensive surgery (e.g., laryngectomy), involvement of other specialty surgeons (e.g., thoracic or reconstructive plastic surgery), or a decision not to operate. Local invasion is also a key component of the AJCC/UICC tumor (T) staging (<xref ref-type="table" rid="T2">Table 2</xref>)<sup>[</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>]</sup>. This staging system focuses on four groups of structures: the airway and nerves centrally (including trachea, esophagus, larynx and pharynx, and recurrent laryngeal nerve (RLN)), the carotid arteries laterally, the prevertebral space posteriorly, and the mediastinum inferiorly.
<table-wrap id="T2" position="float"><label>Table 2</label><caption><p>AJCC TNM staging for thyroid cancer: T staging of DTC and MTC</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">T stage</th><th rowspan="1" colspan="1">Size in greatest dimension</th><th rowspan="1" colspan="1">Presence of invasion</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">T1</td><td rowspan="1" colspan="1">&#x02264;2&#x02009;cm</td><td rowspan="1" colspan="1">No extracapsular invasion</td></tr><tr><td rowspan="1" colspan="1">T2</td><td rowspan="1" colspan="1">&#x0003e;2&#x02009;cm, &#x02264;4&#x02009;cm</td><td rowspan="1" colspan="1">No extracapsular invasion</td></tr><tr><td rowspan="1" colspan="1">T3</td><td rowspan="1" colspan="1">&#x0003e;4&#x02009;cm</td><td rowspan="1" colspan="1">OR minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues)</td></tr><tr><td rowspan="1" colspan="1">T4a</td><td rowspan="1" colspan="1">Any size</td><td rowspan="1" colspan="1">Beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve</td></tr><tr><td rowspan="1" colspan="1">T4b</td><td rowspan="1" colspan="1">Any size</td><td rowspan="1" colspan="1">Prevertebral fascia or encases carotid artery or mediastinal vessels</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>Patients with DTC &#x0003c;45 years of age can only be staged as stage I or II; stage II has metastatic disease (M1).</p></fn><fn id="TF3"><p>For patients with DTC &#x02265;45 years and MTC at any age, M1 determines stage IVc.</p></fn><fn id="TF4"><p>All anaplastic carcinomas are T4a, confined to thyroid, or T4b, invasion beyond the capsule. Therefore, all are Stage IV.</p></fn></table-wrap-foot></table-wrap></p><p>MRI and CT have similar accuracy for predicting local invasion of the esophagus, trachea/larynx and RLN<sup>[</sup><xref ref-type="bibr" rid="B35 B36 B37 B38"><sup>35&#x02013;38</sup></xref><sup>]</sup>. The sensitivity, specificity and accuracy of MRI and CT from several retrospective studies are summarized on <xref ref-type="table" rid="T3">Table 3</xref>. The main sign for tracheal and esophageal invasion on both MRI and CT is a mass contacting 180&#x000b0; or more of the circumference of these organs. Other findings suggesting tracheal invasion are deformity of the lumen, focal mucosal irregularity or thickening, and intraluminal mass (<xref ref-type="fig" rid="F8">Figs. 8</xref> and <xref ref-type="fig" rid="F9">9</xref>)<sup>[</sup><xref ref-type="bibr" rid="B36"><sup>36</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B38"><sup>38</sup></xref><sup>]</sup>. The esophageal wall is more difficult to evaluate than the trachea because it is usually not distended with air. On MRI, the most suspicious finding for esophageal invasion is a focal T2 signal in the outer layer of the esophageal wall. On CT, the radiologist should look for loss of the normal esophageal wall and lumen<sup>[</sup><xref ref-type="bibr" rid="B38"><sup>38</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B39"><sup>39</sup></xref><sup>]</sup>. Invasion of the RLN can be predicted on MRI and CT by effaced fatty tissue in the tracheoesophageal groove where the nerve courses (<xref ref-type="fig" rid="F10">Fig. 10</xref>)<sup>[</sup><xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>]</sup>. Other imaging features of RLN invasion are signs of vocal cord dysfunction (<xref ref-type="fig" rid="F10">Fig. 10</xref>) and 25% or more of the circumference of the primary tumor abutting the capsule at the posterior portion of the thyroid (sign of posterior extracapsular invasion)<sup>[</sup><xref ref-type="bibr" rid="B38"><sup>38</sup></xref><sup>]</sup>.
<fig id="F8" position="float"><label>Figure 8</label><caption><p>A 68-year-old woman with papillary thyroid carcinoma with nodal metastatic disease invading the trachea. (a) Axial T2-weighted image shows a T2 hyperintense mass in the right paratracheal region (arrow) with soft tissue signal in the right tracheal cartilage and an intraluminal mass (arrowhead). (b) Coronal T2-weighted image shows the mass encasing the right brachiocephalic artery (BCA) with loss of the fat plane. There is also a right level IV nodal metastasis (curved arrow). She was treated with radioactive iodine and tracheal stenting. Four months later she presented with massive hemoptysis. CT images at presentation showed progression of disease.</p></caption><graphic xlink:href="ci13001308"/></fig>
<fig id="F9" position="float"><label>Figure 9</label><caption><p>A 65-year-old man with locally invasive and metastatic MTC with tracheal invasion. He presented with a neck mass and had increased calcitonin levels. (a) Axial enhanced CT image shows a large left thyroid lobe mass that mildly narrows the trachea (asterisk), and abuts the esophagus (black arrow) with loss of the fat plane. The mass contacts the vertebral body (arrow), which was concerning for prevertebral space invasion. There is also a large left level IV nodal metastasis that displaces and indents the internal jugular vein (IJV) anteriorly and the common carotid artery (CCA) medially. (b) Coronal reformatted enhanced CT image shows tenting on the inner margin of the left trachea (arrow) suggesting intraluminal tumor extension. At surgery, there was frank invasion of the left trachea and prevertebral space, which precluded curative resection.</p></caption><graphic xlink:href="ci13001309"/></fig>
<fig id="F10" position="float"><label>Figure 10</label><caption><p>A 61-year-old man with anaplastic thyroid carcinoma with invasion of the recurrent laryngeal nerve. He presented with hoarseness. (a) Axial enhanced T1-weighted MRI shows a heterogeneous enhancing mass (arrowheads) in the right lobe of the thyroid. There is loss of the fat plane in the tracheoesophageal groove. The mass abuts the trachea but the mass is &#x0003c;180&#x000b0; around the trachea. There is posterior displacement of the esophagus (arrow), but there is no circumferential mass. (b) Axial enhanced T1-weighted MRI at the level of the true vocal cords shows a dilated right laryngeal ventricle (curved arrow) and anteromedial positioning of the right arytenoid cartilage suggesting vocal cord paralysis. At surgery there was invasion of the right recurrent laryngeal nerve, and perichondrium of the cricoid and 1st to 3rd tracheal rings without deep tracheal invasion. Biopsies of the esophagus were negative. The patient had a total thyroidectomy, followed by chemoradiotherapy. One and two years later he had resection of a right adrenal metastasis and two lung metastases, respectively.</p></caption><graphic xlink:href="ci13001310"/></fig>
<table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Sensitivity, specificity and accuracy of CT and MRI for extrathyroid invasion</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">CT (%)</th><th rowspan="1" colspan="1">CT criteria<sup>[</sup><xref ref-type="bibr" rid="B38"><sup>38</sup></xref><sup>]</sup></th><th rowspan="1" colspan="1">MRI (%)</th><th rowspan="1" colspan="1">MRI criteria</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Trachea</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Sensitivity</td><td rowspan="1" colspan="1">59</td><td rowspan="3" colspan="1">One of:
<list list-type="simple"><list-item><p>&#x02265;180&#x000b0; circumferential contact</p></list-item><list-item><p>Lumen deformity</p></list-item><list-item><p>Mucosal abnormality</p></list-item></list>
</td><td rowspan="1" colspan="1">100</td><td rowspan="3" colspan="1">One of:
<list list-type="simple"><list-item><p>&#x02265;180&#x000b0; circumferential contact</p></list-item><list-item><p>Soft tissue signal in cartilage</p></list-item><list-item><p>Intraluminal mass<sup>[</sup><xref ref-type="bibr" rid="B36"><sup>36</sup></xref><sup>]</sup></p></list-item></list>
</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Specificity</td><td rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1">84</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Accuracy</td><td rowspan="1" colspan="1">83</td><td rowspan="1" colspan="1">90</td></tr><tr><td rowspan="1" colspan="1">Esophagus</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Sensitivity</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">&#x02265;180&#x000b0; circumferential contact OR</td><td rowspan="1" colspan="1">82</td><td rowspan="1" colspan="1">Outer layer invasion<sup>[</sup><xref ref-type="bibr" rid="B37"><sup>37</sup></xref><sup>]</sup></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Specificity</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">Abnormal wall or lumen</td><td rowspan="1" colspan="1">94</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Accuracy</td><td rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1"/></tr><tr><td colspan="5" rowspan="1">Recurrent laryngeal nerve</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Sensitivity</td><td rowspan="1" colspan="1">78</td><td rowspan="3" colspan="1">2 of the following:
<list list-type="simple"><list-item><p>Effaced fatty tissue in tracheoesophageal groove</p></list-item><list-item><p>&#x0003e;25% of tumor abutting posterior portion of thyroid</p></list-item><list-item><p>Signs of ipsilateral vocal cord palsy</p></list-item></list>
</td><td rowspan="1" colspan="1">94</td><td rowspan="3" colspan="1">Effaced fatty tissue in tracheoesophageal groove on at least one axial image<sup>[</sup><xref ref-type="bibr" rid="B35"><sup>35</sup></xref><sup>]</sup></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Specificity</td><td rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1">82</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Accuracy</td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">88</td></tr><tr><td rowspan="1" colspan="1">Carotid artery</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Sensitivity</td><td rowspan="1" colspan="1">75</td><td rowspan="3" colspan="1">
<list list-type="simple"><list-item><p>&#x02265;180&#x000b0; circumferential contact</p></list-item></list>
</td><td rowspan="1" colspan="1">100</td><td rowspan="3" colspan="1">&#x02265;270&#x000b0; circumferential encasement<sup>[</sup><xref ref-type="bibr" rid="B41"><sup>41</sup></xref><sup>]</sup></td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Specificity</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">88</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Accuracy</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">91</td></tr><tr><td colspan="5" rowspan="1">Internal jugular vein</td></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Sensitivity</td><td rowspan="1" colspan="1">33</td><td rowspan="3" colspan="1">
<list list-type="simple"><list-item><p>&#x02265;180&#x000b0; circumferential contact</p></list-item></list>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Specificity</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;&#x02003;Accuracy</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></p><p>Vascular and prevertebral space invasion are designated T4b disease (<xref ref-type="table" rid="T2">Table 2</xref>)<sup>[</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>]</sup>. In general, these findings preclude the patient from curative surgery. Seo et al.<sup>[</sup><xref ref-type="bibr" rid="B38"><sup>38</sup></xref><sup>]</sup> found contact of thyroid tumor with 180&#x000b0; or more of the circumference of the vessel to be a highly specific sign for common carotid artery and internal jugular vein invasion on CT (<xref ref-type="fig" rid="F7">Figs. 7</xref> and <xref ref-type="fig" rid="F8">8</xref>). However, in another study of head and neck tumors, this finding had low accuracy of 50% for arterial invasion due to a high rate of false-negative cases<sup>[</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref><sup>]</sup>. The investigators found that more accurate CT findings for arterial involvement were arterial compression/deformation or fat/fascial plane deletion (accuracy 84%) (<xref ref-type="fig" rid="F8">Fig. 8</xref>)<sup>[</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref><sup>]</sup>. Increasing the criterion of circumferential encasement to 270&#x000b0; also increases the specificity; this sign on MRI had 100% sensitivity and 88% specificity<sup>[</sup><xref ref-type="bibr" rid="B41"><sup>41</sup></xref><sup>]</sup>. On MRI, prevertebral musculature invasion can be excluded if there is preservation of the retropharyngeal fat, but determining invasion with findings of muscle T2 hyperintensity, enhancement, or contour abnormality is less accurate (accuracy &#x0003c;60%)<sup>[</sup><xref ref-type="bibr" rid="B42"><sup>42</sup></xref><sup>]</sup>.</p><p>Cross-sectional imaging has a secondary role in detecting anomalous anatomy that can make surgery more complicated or predispose structures to injury. An example is the non-recurrent inferior laryngeal nerve (NRILN), a variant of the inferior laryngeal nerve. Rather than looping under the right subclavian artery (SCA), the NRILN branches from the vagus and directly enters the larynx. The radiologist can suggest the possibility of a right NRILN when there is an aberrant right SCA<sup>[</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref><sup>]</sup>.</p></sec><sec><title>Evaluating for recurrence in the post-treatment neck</title><p>Serum thyroglobulin level is used as a marker for recurrent or residual DTC. When increased, a neck ultrasonogram and <sup>131</sup>I or <sup>123</sup>I whole-body imaging are typically obtained. The latter may be negative in 50&#x02013;80% of patients and represents progression with dedifferentiated thyroid cancer<sup>[</sup><xref ref-type="bibr" rid="B44"><sup>44</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B45"><sup>45</sup></xref><sup>]</sup>. In such cases, MRI or PET/CT have a role in localizing the tumor for surgery. The outcome may still be curative provided there is complete resection of tumor tissue<sup>[</sup><xref ref-type="bibr" rid="B46"><sup>46</sup></xref><sup>]</sup>. If the metastatic disease is too extensive, the treatment regimen may be changed to a palliative approach.</p><p>MRI can be readily performed for assessment of thyroid recurrence, even if it is not dedifferentiated, because it does not use iodinated contrast. MRI also has the ability to detect nodal disease with high protein content from colloid, thyroglobulin, and blood products (<xref ref-type="fig" rid="F11">Fig. 11</xref>)<sup>[</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>]</sup>. If lateral and central neck dissections have been performed, it becomes even more important to carefully evaluate the retropharyngeal nodal groups<sup>[</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>]</sup>.
<fig id="F11" position="float"><label>Figure 11</label><caption><p>A 41-year-old woman with treated papillary carcinoma and a cystic nodal recurrence. She was initially treated with thyroidectomy and a central neck dissection followed by ablative <sup>131</sup>I therapy. Serum thyroglobulin levels were not increased on follow-up, but a palpable low neck mass was evident. (a) Axial T1-weighted MRI demonstrates a rounded hyperintense lesion (arrow) with a posterior solid nodule (arrowhead) anterior to the right trapezius muscle corresponding to level Vb. The lesion has similar signal intensity to adjacent fat. (b) Axial T2-weighted MRI shows the lesion to be T2 hyperintense (arrow) except for the solid posterior nodule (arrowhead). This was resected and found to be a predominantly cystic papillary thyroid nodal recurrence. The T1 and T2 hyperintense signal likely represents high protein content in the cyst from colloid, thyroglobulin or blood products. Intrinsically hyperintense nodal metastases can be difficult to appreciate on T1 and non-fat-saturated T2 and post-contrast sequences, especially when they are small nodal metastases. Cystic metastases may also be negative on <sup>131</sup>I and PET imaging.</p></caption><graphic xlink:href="ci13001311"/></fig></p><p>PET/CT typically has limited sensitivity for detection of DTC but as the tumor dedifferentiates its tendency to take up FDG increases. The intensity of FDG uptake is correlated with progressive dedifferentiation and a more aggressive tumor, but does not always mean a worse prognosis<sup>[</sup><xref ref-type="bibr" rid="B46"><sup>46</sup></xref><sup>]</sup>. PET/CT has 81&#x02013;82% sensitivity and 64&#x02013;89% specificity for detection of recurrent tumor in the setting of increased serum thyroglobulin level and negative whole-body iodine scan (<xref ref-type="fig" rid="F12">Fig. 12</xref>)<sup>[</sup><xref ref-type="bibr" rid="B45 B46 B47"><sup>45&#x02013;47</sup></xref><sup>]</sup>. A pitfall of PET is that most thyroid nodal metastases are typically small and may be missed by the resolution of PET/CT. Aside from regional metastases, PET/CT can also detect unrecognized distant metastases in the lungs and bones.
<fig id="F12" position="float"><label>Figure 12</label><caption><p>A 24-year-old woman with recurrent metastatic papillary thyroid carcinoma. She was previously treated with total thyroidectomy and selective central compartment neck dissection followed by radioactive iodine therapy. Metastasis was suspected due to an increasing serum thyroglobulin level. (a) Anterior and posterior whole-body images from an <sup>131</sup>I scan show normal salivary pooling in the neck (arrow). There was no abnormal uptake. (b) Axial fused PET/CT shows low-level FDG uptake in subcentimeter left level IIb (arrow) and left parotid nodes (arrowhead). Surgical resection was performed, which confirmed the diagnosis of recurrent papillary thyroid carcinoma in the left lateral nodal groups.</p></caption><graphic xlink:href="ci13001312"/></fig></p><p>Serum calcitonin and carcinoembryonic antigen (CEA) are markers used for detection of otherwise subclinical MTC recurrence. For MTC, FDG-PET uptake can be helpful if positive, but FDG uptake is variable for MTC and even large metastases can be FDG negative<sup>[</sup><xref ref-type="bibr" rid="B48"><sup>48</sup></xref><sup>]</sup>. Therefore, lack of uptake should not be interpreted as absence of disease in MTC. In a study comparing FDG-PET with CT and MRI, the cross-sectional modalities detected a higher percentage of pulmonary and hepatic metastases, but FDG-PET was superior in detecting nodal metastases<sup>[</sup><xref ref-type="bibr" rid="B49"><sup>49</sup></xref><sup>]</sup>. Hence, the combination of CT with PET increases sensitivity and specificity compared with PET alone.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>The radiologist should be aware of the scenarios in which thyroid malignancy can be imaged with CT and MRI and how to approach a thyroid nodule and nodal disease with these modalities. There are clinical and cross-sectional imaging findings that make an ITN more suspicious for malignancy. For known malignancy, CT and MRI are helpful for detecting extrathyroid invasion. Knowledge of the behavior and appearance of nodal metastases on CT and MRI is crucial for preoperative assessment and for evaluation of recurrent tumor.</p></sec><sec><title>Conflict of interest</title><p>C.M. Glastonbury is an investor in and consultant for Amirsys.</p></sec></body><back><fn-group><fn><p>This paper is available online at <ext-link ext-link-type="uri" xlink:href="http://www.cancerimaging.org">http://www.cancerimaging.org</ext-link>. In the event of a change in the URL address, please use the DOI provided to locate the paper.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>WK</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Farrell</surname><given-names>S</given-names></name></person-group><article-title>US features of thyroid malignancy: pearls and pitfalls</article-title><source>Radiographics</source><year>2007</year><volume>27</volume><fpage>847</fpage><lpage>860</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1148/rg.273065038">doi:10.1148/rg.273065038</ext-link>. PMid:17495296</comment><pub-id pub-id-type="pmid">17495296</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>DS</given-names></name><name><surname>Doherty</surname><given-names>GM</given-names></name><name><surname>Haugen</surname><given-names>BR</given-names></name><etal/></person-group><article-title>Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer</article-title><source>Thyroid</source><year>2009</year><volume>19</volume><fpage>1167</fpage><lpage>1214</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/thy.2009.0110">doi:10.1089/thy.2009.0110</ext-link>. PMid:19860577</comment><pub-id pub-id-type="pmid">19860577</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="webpage"><collab>National Cancer Institute</collab><article-title>Surveillance Epidemiology and End Results Data 1983 to 2009</article-title><comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://seer.cancer.gov/">http://seer.cancer.gov/</ext-link> (accessed December 2012)</comment></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hundahl</surname><given-names>SA</given-names></name><name><surname>Fleming</surname><given-names>ID</given-names></name><name><surname>Fremgen</surname><given-names>AM</given-names></name><name><surname>Menck</surname><given-names>HR</given-names></name></person-group><article-title>A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985&#x02013;1995</article-title><source>Cancer</source><year>1998</year><volume>83</volume><fpage>2638</fpage><lpage>2648</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/(SICI)1097-0142(19981215)83:12&#x0003c;2638::AID-CNCR31&#x0003e;3.0.CO;2-1">doi:10.1002/(SICI)1097-0142(19981215)83:12&#x0003c;2638::AID-CNCR31&#x0003e;3.0.CO;2-1</ext-link>. PMid:9874472</comment><pub-id pub-id-type="pmid">9874472</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>L</given-names></name><name><surname>Welch</surname><given-names>HG</given-names></name></person-group><article-title>Increasing incidence of thyroid cancer in the United States, 1973&#x02013;2002</article-title><source>JAMA</source><year>2006</year><volume>295</volume><fpage>2164</fpage><lpage>2167</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.295.18.2164">doi:10.1001/jama.295.18.2164</ext-link>. PMid:16684987</comment><pub-id pub-id-type="pmid">16684987</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Miyauchi</surname><given-names>A</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><etal/></person-group><article-title>An observational trial for papillary thyroid microcarcinoma in Japanese patients</article-title><source>World J Surg</source><year>2010</year><volume>34</volume><fpage>28</fpage><lpage>35</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00268-009-0303-0">doi:10.1007/s00268-009-0303-0</ext-link>. PMid:20020290</comment><pub-id pub-id-type="pmid">20020290</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Edge</surname><given-names>SB</given-names></name></person-group><collab>American Joint Committee on Cancer</collab><source>AJCC cancer staging manual</source><year>2010</year><edition>7th ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Springer</publisher-name><fpage>xiv, 648</fpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niccoli-Sire</surname><given-names>P</given-names></name><name><surname>Murat</surname><given-names>A</given-names></name><name><surname>Rohmer</surname><given-names>V</given-names></name><etal/></person-group><article-title>Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>3746</fpage><lpage>3753</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/jc.86.8.3746">doi:10.1210/jc.86.8.3746</ext-link>. PMid:11502806</comment><pub-id pub-id-type="pmid">11502806</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luster</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>SE</given-names></name><name><surname>Dietlein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Guidelines for radioiodine therapy of differentiated thyroid cancer</article-title><source>Eur J Nucl Med Mol Imaging</source><year>2008</year><volume>35</volume><fpage>1941</fpage><lpage>1959</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00259-008-0883-1">doi:10.1007/s00259-008-0883-1</ext-link>. PMid:18670773</comment><pub-id pub-id-type="pmid">18670773</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Molen</surname><given-names>AJ</given-names></name><name><surname>Thomsen</surname><given-names>HS</given-names></name><name><surname>Morcos</surname><given-names>SK</given-names></name></person-group><article-title>Effect of iodinated contrast media on thyroid function in adults</article-title><source>Eur Radiol</source><year>2004</year><volume>14</volume><fpage>902</fpage><lpage>907</lpage><comment>PMid:14997334</comment><pub-id pub-id-type="pmid">14997334</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>X</given-names></name><name><surname>Roy Choudhury</surname><given-names>K</given-names></name><name><surname>Lyman</surname><given-names>GH</given-names></name><etal/></person-group><article-title>Incidental thyroid nodules on CT: comparison of two risk categorization methods for workup of nodules</article-title><source>AJNR Am J Neuroradiol</source><year>2013</year></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousem</surname><given-names>DM</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Loevner</surname><given-names>LA</given-names></name><name><surname>Langlotz</surname><given-names>CP</given-names></name></person-group><article-title>Clinical and economic impact of incidental thyroid lesions found with CT and MR</article-title><source>AJNR Am J Neuroradiol</source><year>1997</year><volume>18</volume><fpage>1423</fpage><lpage>1428</lpage><pub-id pub-id-type="pmid">9296181</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>DY</given-names></name><name><surname>Chang</surname><given-names>SK</given-names></name><name><surname>Choi</surname><given-names>CS</given-names></name><etal/></person-group><article-title>The prevalence and significance of incidental thyroid nodules identified on computed tomography</article-title><source>J Comput Assist Tomogr</source><year>2008</year><volume>32</volume><fpage>810</fpage><lpage>815</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/RCT.0b013e318157fd38">doi:10.1097/RCT.0b013e318157fd38</ext-link>. PMid:18830117</comment><pub-id pub-id-type="pmid">18830117</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shie</surname><given-names>P</given-names></name><name><surname>Cardarelli</surname><given-names>R</given-names></name><name><surname>Sprawls</surname><given-names>K</given-names></name><name><surname>Fulda</surname><given-names>KG</given-names></name><name><surname>Taur</surname><given-names>A</given-names></name></person-group><article-title>Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography</article-title><source>Nucl Med Commun</source><year>2009</year><volume>30</volume><fpage>742</fpage><lpage>748</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MNM.0b013e32832ee09d">doi:10.1097/MNM.0b013e32832ee09d</ext-link>. PMid:19561553</comment><pub-id pub-id-type="pmid">19561553</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eloy</surname><given-names>JA</given-names></name><name><surname>Brett</surname><given-names>EM</given-names></name><name><surname>Fatterpekar</surname><given-names>GM</given-names></name><etal/></person-group><article-title>The significance and management of incidental [<sup>18</sup>F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer</article-title><source>AJNR Am J Neuroradiol</source><year>2009</year><volume>30</volume><fpage>1431</fpage><lpage>1434</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3174/ajnr.A1559">doi:10.3174/ajnr.A1559</ext-link>. PMid:19342543</comment><pub-id pub-id-type="pmid">19342543</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>JK</given-names></name><name><surname>Raduazo</surname><given-names>P</given-names></name><name><surname>Yousem</surname><given-names>DM</given-names></name><name><surname>Eastwood</surname><given-names>JD</given-names></name></person-group><article-title>What to do with incidental thyroid nodules on imaging? An approach for the radiologist</article-title><source>Semin Ultrasound CT MR</source><year>2012</year><volume>33</volume><fpage>150</fpage><lpage>157</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1053/j.sult.2011.12.004">doi:10.1053/j.sult.2011.12.004</ext-link>. PMid:22410363</comment><pub-id pub-id-type="pmid">22410363</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razek</surname><given-names>AA</given-names></name><name><surname>Sadek</surname><given-names>AG</given-names></name><name><surname>Kombar</surname><given-names>OR</given-names></name><name><surname>Elmahdy</surname><given-names>TE</given-names></name><name><surname>Nada</surname><given-names>N</given-names></name></person-group><article-title>Role of apparent diffusion coefficient values in differentiation between malignant and benign solitary thyroid nodules</article-title><source>AJNR Am J Neuroradiol</source><year>2008</year><volume>29</volume><fpage>563</fpage><lpage>568</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3174/ajnr.A0849">doi:10.3174/ajnr.A0849</ext-link>. PMid:18039755</comment><pub-id pub-id-type="pmid">18039755</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozgeyik</surname><given-names>Z</given-names></name><name><surname>Coskun</surname><given-names>S</given-names></name><name><surname>Dagli</surname><given-names>AF</given-names></name><name><surname>Ozkan</surname><given-names>Y</given-names></name><name><surname>Sahpaz</surname><given-names>F</given-names></name><name><surname>Ogur</surname><given-names>E</given-names></name></person-group><article-title>Diffusion-weighted MR imaging of thyroid nodules</article-title><source>Neuroradiology</source><year>2009</year><volume>51</volume><fpage>193</fpage><lpage>198</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00234-008-0494-3">doi:10.1007/s00234-008-0494-3</ext-link>. PMid:19165474</comment><pub-id pub-id-type="pmid">19165474</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartolotta</surname><given-names>TV</given-names></name><name><surname>Midiri</surname><given-names>M</given-names></name><name><surname>Runza</surname><given-names>G</given-names></name><etal/></person-group><article-title>Incidentally discovered thyroid nodules: incidence, and greyscale and colour Doppler pattern in an adult population screened by real-time compound spatial sonography</article-title><source>Radiol Med</source><year>2006</year><volume>111</volume><fpage>989</fpage><lpage>998</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11547-006-0097-1">doi:10.1007/s11547-006-0097-1</ext-link>. PMid:17021683</comment><pub-id pub-id-type="pmid">17021683</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brander</surname><given-names>A</given-names></name><name><surname>Viikinkoski</surname><given-names>P</given-names></name><name><surname>Nickels</surname><given-names>J</given-names></name><name><surname>Kivisaari</surname><given-names>L</given-names></name></person-group><article-title>Thyroid gland: US screening in a random adult population</article-title><source>Radiology</source><year>1991</year><volume>181</volume><fpage>683</fpage><lpage>687</lpage><comment>PMid:1947082</comment><pub-id pub-id-type="pmid">1947082</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brander</surname><given-names>AE</given-names></name><name><surname>Viikinkoski</surname><given-names>VP</given-names></name><name><surname>Nickels</surname><given-names>JI</given-names></name><name><surname>Kivisaari</surname><given-names>LM</given-names></name></person-group><article-title>Importance of thyroid abnormalities detected at US screening: a 5-year follow-up</article-title><source>Radiology</source><year>2000</year><volume>215</volume><fpage>801</fpage><lpage>806</lpage><comment>PMid:10831702</comment><pub-id pub-id-type="pmid">10831702</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steele</surname><given-names>SR</given-names></name><name><surname>Martin</surname><given-names>MJ</given-names></name><name><surname>Mullenix</surname><given-names>PS</given-names></name><name><surname>Azarow</surname><given-names>KS</given-names></name><name><surname>Andersen</surname><given-names>CA</given-names></name></person-group><article-title>The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography</article-title><source>Arch Surg</source><year>2005</year><volume>140</volume><fpage>981</fpage><lpage>985</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archsurg.140.10.981">doi:10.1001/archsurg.140.10.981</ext-link>. PMid:16230549</comment><pub-id pub-id-type="pmid">16230549</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harach</surname><given-names>HR</given-names></name><name><surname>Franssila</surname><given-names>KO</given-names></name><name><surname>Wasenius</surname><given-names>VM</given-names></name></person-group><article-title>Occult papillary carcinoma of the thyroid. A &#x0201c;normal&#x0201d; finding in Finland. A systematic autopsy study</article-title><source>Cancer</source><year>1985</year><volume>56</volume><fpage>531</fpage><lpage>538</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/1097-0142(19850801)56:3&#x0003c;531::AID-CNCR2820560321&#x0003e;3.0.CO;2-3">doi:10.1002/1097-0142(19850801)56:3&#x0003c;531::AID-CNCR2820560321&#x0003e;3.0.CO;2-3</ext-link>. PMid:2408737</comment><pub-id pub-id-type="pmid">2408737</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frates</surname><given-names>MC</given-names></name><name><surname>Benson</surname><given-names>CB</given-names></name><name><surname>Charboneau</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement</article-title><source>Radiology</source><year>2005</year><volume>237</volume><fpage>794</fpage><lpage>800</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1148/radiol.2373050220">doi:10.1148/radiol.2373050220</ext-link>. PMid:16304103</comment><pub-id pub-id-type="pmid">16304103</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>PT</given-names></name><name><surname>Horton</surname><given-names>KM</given-names></name><name><surname>Megibow</surname><given-names>AJ</given-names></name><name><surname>Jeffrey</surname><given-names>RB</given-names></name><name><surname>Fishman</surname><given-names>EK</given-names></name></person-group><article-title>Common incidental findings on MDCT: survey of radiologist recommendations for patient management</article-title><source>J Am Coll Radiol</source><year>2011</year><volume>8</volume><fpage>762</fpage><lpage>767</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jacr.2011.05.012">doi:10.1016/j.jacr.2011.05.012</ext-link>. PMid:22051458</comment><pub-id pub-id-type="pmid">22051458</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shetty</surname><given-names>SK</given-names></name><name><surname>Maher</surname><given-names>MM</given-names></name><name><surname>Hahn</surname><given-names>PF</given-names></name><name><surname>Halpern</surname><given-names>EF</given-names></name><name><surname>Aquino</surname><given-names>SL</given-names></name></person-group><article-title>Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology</article-title><source>AJR Am J Roentgenol</source><year>2006</year><volume>187</volume><fpage>1349</fpage><lpage>1356</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/AJR.05.0468">doi:10.2214/AJR.05.0468</ext-link>. PMid:17056928</comment><pub-id pub-id-type="pmid">17056928</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>JK</given-names></name><name><surname>Vanka</surname><given-names>J</given-names></name><name><surname>Ludwig</surname><given-names>BJ</given-names></name><name><surname>Glastonbury</surname><given-names>CM</given-names></name></person-group><article-title>Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach</article-title><source>AJR Am J Roentgenol</source><year>2013</year><volume>200</volume><fpage>W17</fpage><lpage>25</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/AJR.12.8960">doi:10.2214/AJR.12.8960</ext-link>. PMid:23255768</comment><pub-id pub-id-type="pmid">23255768</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Som</surname><given-names>PM</given-names></name><name><surname>Curtin</surname><given-names>HD</given-names></name><name><surname>Mancuso</surname><given-names>AA</given-names></name></person-group><article-title>Imaging-based nodal classification for evaluation of neck metastatic adenopathy</article-title><source>AJR Am J Roentgenol</source><year>2000</year><volume>174</volume><fpage>837</fpage><lpage>844</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/ajr.174.3.1740837">doi:10.2214/ajr.174.3.1740837</ext-link>. PMid:10701636</comment><pub-id pub-id-type="pmid">10701636</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>IC</given-names></name><name><surname>Park</surname><given-names>JO</given-names></name><name><surname>Joo</surname><given-names>YH</given-names></name><name><surname>Cho</surname><given-names>KJ</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name></person-group><article-title>Pattern and predictive factors of regional lymph node metastasis in papillary thyroid carcinoma: a prospective study</article-title><source>Head Neck</source><year>2013</year><volume>35</volume><fpage>40</fpage><lpage>45</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hed.22903">doi:10.1002/hed.22903</ext-link>. PMid:22266805</comment><pub-id pub-id-type="pmid">22266805</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>JD</given-names></name><name><surname>McMullen</surname><given-names>TP</given-names></name><name><surname>Sidhu</surname><given-names>SB</given-names></name><name><surname>Sywak</surname><given-names>MS</given-names></name><name><surname>Robinson</surname><given-names>BG</given-names></name><name><surname>Delbridge</surname><given-names>LW</given-names></name></person-group><article-title>Predictive value of the Delphian and level VI nodes in papillary thyroid cancer</article-title><source>ANZ J Surg</source><year>2010</year><volume>80</volume><fpage>834</fpage><lpage>838</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1445-2197.2010.05334.x">doi:10.1111/j.1445-2197.2010.05334.x</ext-link>. PMid:20969694</comment><pub-id pub-id-type="pmid">20969694</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>SL</given-names></name><name><surname>Mandel</surname><given-names>SJ</given-names></name><name><surname>Muller</surname><given-names>R</given-names></name><name><surname>Baloch</surname><given-names>ZW</given-names></name><name><surname>Thaler</surname><given-names>ER</given-names></name><name><surname>Loevner</surname><given-names>LA</given-names></name></person-group><article-title>The role of MR imaging in detecting nodal disease in thyroidectomy patients with rising thyroglobulin levels</article-title><source>AJNR Am J Neuroradiol</source><year>2009</year><volume>30</volume><fpage>608</fpage><lpage>612</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3174/ajnr.A1405">doi:10.3174/ajnr.A1405</ext-link>. PMid:19039052</comment><pub-id pub-id-type="pmid">19039052</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>YS</given-names></name><name><surname>Park</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name></person-group><article-title>Experience and analysis of level VII cervical lymph node metastases in patients with papillary thyroid carcinoma</article-title><source>J Korean Surg Soc</source><year>2011</year><volume>80</volume><fpage>307</fpage><lpage>312</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4174/jkss.2011.80.5.307">doi:10.4174/jkss.2011.80.5.307</ext-link>. PMid:22066053</comment><pub-id pub-id-type="pmid">22066053</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Sone</surname><given-names>S</given-names></name><name><surname>Takayama</surname><given-names>F</given-names></name><etal/></person-group><article-title>Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis</article-title><source>AJNR Am J Neuroradiol</source><year>1998</year><volume>19</volume><fpage>509</fpage><lpage>513</lpage><comment>PMid:9541309</comment><pub-id pub-id-type="pmid">9541309</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machens</surname><given-names>A</given-names></name><name><surname>Holzhausen</surname><given-names>HJ</given-names></name><name><surname>Dralle</surname><given-names>H</given-names></name></person-group><article-title>Skip metastases in thyroid cancer leaping the central lymph node compartment</article-title><source>Arch Surg</source><year>2004</year><volume>139</volume><fpage>43</fpage><lpage>45</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archsurg.139.1.43">doi:10.1001/archsurg.139.1.43</ext-link>. PMid:14718274</comment><pub-id pub-id-type="pmid">14718274</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Takayama</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><name><surname>Kadoya</surname><given-names>M</given-names></name></person-group><article-title>Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid carcinoma</article-title><source>AJR Am J Roentgenol</source><year>2003</year><volume>180</volume><fpage>837</fpage><lpage>842</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/ajr.180.3.1800837">doi:10.2214/ajr.180.3.1800837</ext-link>. PMid:12591706</comment><pub-id pub-id-type="pmid">12591706</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Takayama</surname><given-names>F</given-names></name><etal/></person-group><article-title>Tracheal invasion by thyroid carcinoma: prediction using MR imaging</article-title><source>AJR Am J Roentgenol</source><year>2001</year><volume>177</volume><fpage>929</fpage><lpage>936</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/ajr.177.4.1770929">doi:10.2214/ajr.177.4.1770929</ext-link>. PMid:11566708</comment><pub-id pub-id-type="pmid">11566708</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Takashima</surname><given-names>S</given-names></name><name><surname>Matsushita</surname><given-names>T</given-names></name><name><surname>Takayama</surname><given-names>F</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Kadoya</surname><given-names>M</given-names></name></person-group><article-title>Esophageal invasion by thyroid carcinomas: prediction using magnetic resonance imaging</article-title><source>J Comput Assist Tomogr</source><year>2003</year><volume>27</volume><fpage>18</fpage><lpage>25</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/00004728-200301000-00004">doi:10.1097/00004728-200301000-00004</ext-link>. PMid:12544237</comment><pub-id pub-id-type="pmid">12544237</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>YL</given-names></name><name><surname>Yoon</surname><given-names>DY</given-names></name><name><surname>Lim</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures?</article-title><source>AJR Am J Roentgenol</source><year>2010</year><volume>195</volume><fpage>W240</fpage><lpage>244</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/AJR.09.3965">doi:10.2214/AJR.09.3965</ext-link>. PMid:20729422</comment><pub-id pub-id-type="pmid">20729422</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roychowdhury</surname><given-names>S</given-names></name><name><surname>Loevner</surname><given-names>LA</given-names></name><name><surname>Yousem</surname><given-names>DM</given-names></name><name><surname>Chalian</surname><given-names>A</given-names></name><name><surname>Montone</surname><given-names>KT</given-names></name></person-group><article-title>MR imaging for predicting neoplastic invasion of the cervical esophagus</article-title><source>AJNR Am J Neuroradiol</source><year>2000</year><volume>21</volume><fpage>1681</fpage><lpage>1687</lpage><comment>PMid:11039351</comment><pub-id pub-id-type="pmid">11039351</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name></person-group><article-title>Carotid artery and jugular vein invasion of oral-maxillofacial and neck malignant tumors: diagnostic value of computed tomography</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2003</year><volume>96</volume><fpage>368</fpage><lpage>372</lpage><comment>PMid:12973296</comment><pub-id pub-id-type="pmid">12973296</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousem</surname><given-names>DM</given-names></name><name><surname>Hatabu</surname><given-names>H</given-names></name><name><surname>Hurst</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Carotid artery invasion by head and neck masses: prediction with MR imaging</article-title><source>Radiology</source><year>1995</year><volume>195</volume><fpage>715</fpage><lpage>720</lpage><comment>PMid:7754000</comment><pub-id pub-id-type="pmid">7754000</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loevner</surname><given-names>LA</given-names></name><name><surname>Ott</surname><given-names>IL</given-names></name><name><surname>Yousem</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Neoplastic fixation to the prevertebral compartment by squamous cell carcinoma of the head and neck</article-title><source>AJR Am J Roentgenol</source><year>1998</year><volume>170</volume><fpage>1389</fpage><lpage>1394</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2214/ajr.170.5.9574622">doi:10.2214/ajr.170.5.9574622</ext-link>. PMid:9574622</comment><pub-id pub-id-type="pmid">9574622</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>O</given-names></name><name><surname>Hirokazu</surname><given-names>K</given-names></name><name><surname>Takayoshi</surname><given-names>Y</given-names></name><name><surname>Fumio</surname><given-names>K</given-names></name></person-group><article-title>Nonrecurrent inferior laryngeal nerve in patients with esophageal cancer: report of two cases</article-title><source>Esophagus</source><year>2007</year><volume>4</volume><fpage>41</fpage><lpage>45</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10388-006-0099-z">doi:10.1007/s10388-006-0099-z</ext-link></comment></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loevner</surname><given-names>LA</given-names></name><name><surname>Kaplan</surname><given-names>SL</given-names></name><name><surname>Cunnane</surname><given-names>ME</given-names></name><name><surname>Moonis</surname><given-names>G</given-names></name></person-group><article-title>Cross-sectional imaging of the thyroid gland</article-title><source>Neuroimaging Clin North Am</source><year>2008</year><volume>18</volume><fpage>445</fpage><lpage>461, vii</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.nic.2008.05.001">doi:10.1016/j.nic.2008.05.001</ext-link></comment></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razfar</surname><given-names>A</given-names></name><name><surname>Branstetter</surname><given-names>BFt</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><etal/></person-group><article-title>Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma</article-title><source>Arch Otolaryngol Head Neck Surg</source><year>2010</year><volume>136</volume><fpage>120</fpage><lpage>125</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archoto.2009.215">doi:10.1001/archoto.2009.215</ext-link>. PMid:20157055</comment><pub-id pub-id-type="pmid">20157055</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schluter</surname><given-names>B</given-names></name><name><surname>Bohuslavizki</surname><given-names>KH</given-names></name><name><surname>Beyer</surname><given-names>W</given-names></name><name><surname>Plotkin</surname><given-names>M</given-names></name><name><surname>Buchert</surname><given-names>R</given-names></name><name><surname>Clausen</surname><given-names>M</given-names></name></person-group><article-title>Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative <sup>131</sup>I scan</article-title><source>J Nucl Med</source><year>2001</year><volume>42</volume><fpage>71</fpage><lpage>76</lpage><comment>PMid:11197983</comment><pub-id pub-id-type="pmid">11197983</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteva</surname><given-names>D</given-names></name><name><surname>Muros</surname><given-names>MA</given-names></name><name><surname>Llamas-Elvira</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Clinical and pathological factors related to <sup>18</sup>F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer</article-title><source>Ann Surg Oncol</source><year>2009</year><volume>16</volume><fpage>2006</fpage><lpage>2013</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1245/s10434-009-0483-8">doi:10.1245/s10434-009-0483-8</ext-link>. PMid:19415387</comment><pub-id pub-id-type="pmid">19415387</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>SC</given-names></name><name><surname>Schoder</surname><given-names>H</given-names></name><name><surname>Patel</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels</article-title><source>J Nucl Med</source><year>2007</year><volume>48</volume><fpage>501</fpage><lpage>507</lpage><comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2967/jnumed.106.036681">doi:10.2967/jnumed.106.036681</ext-link>. PMid:17401085</comment><pub-id pub-id-type="pmid">17401085</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szakall</surname><given-names>S</given-names><suffix>Jr.</suffix></name><name><surname>Esik</surname><given-names>O</given-names></name><name><surname>Bajzik</surname><given-names>G</given-names></name><etal/></person-group><article-title><sup>18</sup>F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma</article-title><source>J Nucl Med</source><year>2002</year><volume>43</volume><fpage>66</fpage><lpage>71</lpage><comment>PMid:11801705</comment><pub-id pub-id-type="pmid">11801705</pub-id></element-citation></ref></ref-list></back></article>